Glioneuronal and Neuronal Tumors of the Central Nervous System

Martinoni, Matteo; Fabbri, Viscardo Paolo; Corte, Emanuele La; Zucchelli, Mino; Toni, Francesco; Asioli, Sofia; Giannini, Caterina

doi:10.1007/978-3-031-23705-8_9

Search citation statements

Order By: Relevance

Paper Sections

Select...

Introduction1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 87 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The Central Brain Tumor Registry of the United States Statistical Report revealed that GNTs account for only 1.2% of intracranial tumors [2]. While most GNTs are benign, symptomatic cases can cause various problems, including headaches, epilepsy, nausea, and visual disturbances [3].…”

Section: Introductionmentioning

confidence: 99%

Central Neurocytoma Treated Using Supratentorial Ventricle Radiotherapy: A Single-Institution Analysis of Five Cases in Adjuvant or Salvage Settings After Surgery

Maemura,

Katano,

Takami

et al. 2024

Cureus

View full text Add to dashboard Cite

Introduction: Central neurocytoma (CN) is an extremely rare tumor primarily located in the supratentorial ventricular system, categorized as a glioneuronal or neuronal tumor.Methods: This study presented a retrospective analysis of five CN patients who received adjuvant or salvage radiotherapy. Patients, aged 31-59 years, underwent radiation doses ranging from 60 Gy to 50.4 Gy over 27-30 fractions.Results: All patients achieved effective local tumor control without severe complications. The median follow-up period was 51.7 months, demonstrating 100% overall and progression-free survival rates.Discussion: Our study's clinical outcomes align with previous research, despite the limitation of a small sample size. Emphasizing the necessity for additional research, our findings added to the potential evidence of radiotherapy in managing CN. Larger, long-term studies were needed to confirm these promising results.

show abstract

Section: Introductionmentioning

confidence: 99%